Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Avocado Fruit on Postprandial Markers of the Glycemic Response, Satiety/Appetite and Cardiometabolic Risk (AVOC1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02479048
Recruitment Status : Active, not recruiting
First Posted : June 23, 2015
Last Update Posted : May 28, 2019
Sponsor:
Information provided by (Responsible Party):
Institute for Food Safety and Health, United States

Brief Summary:
The primary goal is to characterize the acute effects of avocado intake on glycemic and satiety/ appetite responses in relatively healthy overweight / obese adults. The secondary goal is to investigate risk factors for cardio-metabolic disease.

Condition or disease Intervention/treatment Phase
Glycemic Response Dietary Supplement: Test meal 1 Dietary Supplement: Test meal 2 Dietary Supplement: Control Meal (CM) Not Applicable

Detailed Description:

The trial is a single center randomized, 3-arm, controlled, within-subject crossover study utilizing a multiple sampling, repeated measures paradigm. The trial will test 3 treatment conditions in 30 relatively healthy men and women 25-60 years of age. Study treatments include Control (without avocado), Test Meal 1 (1/2 avocado; ~68g), and Test Meal 2 (1 Avocado; ~136g).

Subjects will be required to meet several inclusion and exclusion criteria, which will be assessed through online and clinic mechanisms, including questionnaires, blood analysis and anthropometric measures. Eligible subjects will be invited to participate in the study. Each subject will be asked to come for one Information Session/Screening Visit, one Pre-Study Visit, three dinner pick-ups (the day before each test day visit) and three Test Day Visits. Subjects will be randomized to receive test treatments based on randomization schedule at the Pre-Study Visit.

During the Pre-Study Visit subjects will be instructed on the process for completing study questionnaires and counseled to restrict avocado intake and intake of colored plant foods rich in phytonutrients the 3 days prior to each Test Day Visit. They will be asked to restrict alcohol intake, coffee/tea/ caffeinated beverage intake and moderate / vigorous physical activity and to drink plenty of water to maintain hydration in the 24 h prior to each Test Day Visit. They will be instructed to come to the CNRC the day before each Test Day Visit to pick up their dinner meal and evening snack. Subjects will be asked to get at least 7 hours sleep and to come to the CNRC after an overnight fast of 10 h on each Test Day Visit.

Each Test Day Visit will require subjects to be in the clinic for ~7 h to complete all baseline and post challenge meal testing procedures. Subjects will be evaluated for compliance with the protocol (diet, exercise, sleep, fasting), have their body weight and blood pressure measured and baseline flow mediated dilation (FMD) will be recoded before placement of a catheter and baseline blood sample is taken. Baseline subjective satiety will be measured by visual analogue scale (VAS) just before consuming one of the 3 breakfast treatment meals. FMD will be measured at 2 time points after breakfast and blood samples and VAS questionnaires will be collected at multiple time points over the 6 h postprandial period.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 24 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Participant)
Primary Purpose: Other
Official Title: The Impact of Avocado Fruit on Postprandial Markers of the Glycemic Response, Satiety/Appetite and Cardiometabolic Risk: An Acute Dose Response Study
Actual Study Start Date : June 1, 2015
Estimated Primary Completion Date : October 1, 2019
Estimated Study Completion Date : October 1, 2019

Arm Intervention/treatment
Active Comparator: Test meal 1 (TM1)
High fat meal (HF) with ½ avocado (~68g)
Dietary Supplement: Test meal 1
High fat meal (HF) with ½ avocado (~68g), matched to CM for energy content; not matched for macronutrient content or type (e.g., fat type).

Active Comparator: Test meal 2 (TM2)
High fat meal (HF) with 1 avocado (~136g)
Dietary Supplement: Test meal 2
High fat meal (HF) with 1 avocado (~136g) matched for energy but not macronutrient content or type.

Placebo Comparator: Control meal (CM)
High carbohydrate, high saturated fat control meal (CM) without avocado.
Dietary Supplement: Control Meal (CM)
High carbohydrate, high saturated fat control meal (CM) without avocado.




Primary Outcome Measures :
  1. Change in postprandial blood glucose concentration response for treatments compared to control over 6-hour postprandial period [ Time Frame: Baseline to 6 hours ]
    postprandial blood glucose concentration response


Secondary Outcome Measures :
  1. Changes in postprandial endothelial function using Flow Mediated Dilation (FMD) for treatments compared to control [ Time Frame: Baseline to 6 hours ]
    postprandial endothelial function using Flow Mediated Dilation (FMD)

  2. Change in postprandial blood insulin and triglycerides concentration response for treatments compared to control over 6-hour postprandial period [ Time Frame: Baseline to 6 hours ]
    postprandial blood insulin and triglycerides concentration response

  3. Changes in postprandial subjective satiety responses using visual analog scales (VAS) for treatments compared to control over 6-hour postprandial period [ Time Frame: Baseline to 6 hours ]
    postprandial subjective satiety responses using visual analog scales (VAS)

  4. Changes in postprandial gut hormones related to satiety for treatments compared to control over 6-hour postprandial period [ Time Frame: Baseline to 6 hours ]
    postprandial gut hormones related to satiety for treatments


Other Outcome Measures:
  1. Changes in postprandial lipoproteins responses for treatments compared to control [ Time Frame: Baseline to 6 hours ]
    postprandial lipoproteins responses

  2. Changes in postprandial inflammation responses for treatments compared to control [ Time Frame: Baseline to 6 hours ]
    postprandial inflammation responses

  3. Changes in postprandial oxidation responses for treatments compared to control [ Time Frame: Baseline to 6 hours ]
    postprandial oxidation responses



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   25 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Men and women aged 25-60 yrs.
  • BMI of 25 - 35 kg/m2
  • No clinical evidence / history of cardiovascular, respiratory, renal, gastrointestinal, or hepatic disease
  • Not taking over-the-counter or prescription medications / dietary supplements that may interfere with study procedures or endpoints (e.g., antioxidant supplements, anti-inflammatory, lipid-lowering or blood pressure lowering medications.
  • Fasting blood glucose of 90-115 mg/dl
  • Fasting insulin < 13 U/L
  • Non-smoker or past smoker (smoking cessation > 2 yrs.)
  • has at least 1 large, sturdy and well anchored vein in order to place a catheter

Exclusion Criteria:

  • Aged < 25 or > 60 years
  • BMI < 25 kg/m2 or > 35 kg/m2
  • History of cardiovascular, respiratory, renal, gastrointestinal or hepatic disease
  • Diabetes
  • Uncontrolled blood pressure (>140 / 90 mmHg)
  • Have or had cancer other than non-melanoma skin cancer in past 5 years
  • Taking over-the-counter or prescription medications or dietary supplements that may interfere with study procedures or endpoints (including protein powers, energy drinks)
  • Fasting blood glucose <90 or > 115 mg/dl
  • Fasting insulin ≥ 13 U/L
  • Vegan dietary habits, unusual dietary habits or sensitive or allergic to any of the test meal components / ingredients
  • Dislike avocados or non-consumers of avocados
  • Current smoker
  • Actively losing weight or trying to lose weight
  • Drug or alcohol addiction
  • Present with significant psychiatric or neurological disturbances
  • Pregnant, lactating or planning to become pregnant
  • Consuming 3 or more servings nuts or peanuts per week
  • has no accessible vein site for placing a catheter

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02479048


Locations
Layout table for location information
United States, Illinois
Clinical Nutrition Research Center
Chicago, Illinois, United States, 60616
Sponsors and Collaborators
Institute for Food Safety and Health, United States
Investigators
Layout table for investigator information
Principal Investigator: Britt Burton-Freeman, Ph.D Illinois Institute of Technology

Layout table for additonal information
Responsible Party: Institute for Food Safety and Health, United States
ClinicalTrials.gov Identifier: NCT02479048    
Other Study ID Numbers: IRB2015-001
First Posted: June 23, 2015    Key Record Dates
Last Update Posted: May 28, 2019
Last Verified: May 2019
Keywords provided by Institute for Food Safety and Health, United States:
satiety/appetite
glycemic response
cardiometabolic risk